Access and Disparities in Pancreatic Cancer Surgery Remain Pervasive Problems
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities.
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities.
If your tumor is operable and in the tail you may qualify for a distal pancreatectomy. Learn more about this suregery for pancreatic cancer.
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.
Despite no known genetic link, Steven Robinson is the fourth member of his family on his mother’s side to get pancreatic cancer.
Gene Waters was fortunate that a follow-up for tonsil cancer found his pancreatic cancer early. He got a second opinion for his treatment.
Is chemotherapy before and after pancreatic cancer surgery more effective than just chemotherapy after surgery?